BTIG Starts Neuronetics (STIM) at Buy

July 20, 2026 5:57 AM

BTIG analyst Sam Eiber initiates coverage on Neuronetics (NASDAQ: STIM) with a Buy rating and a price target of $5.00.The ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found